Literature DB >> 12825931

Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes.

Susan L McGovern1, Brian K Shoichet.   

Abstract

Molecular docking uses the three-dimensional structure of a receptor to screen a small molecule database for potential ligands. The dependence of docking screens on the conformation of the binding site remains an open question. To evaluate the information loss that occurs as the active site conformation becomes less defined, a small molecule database was docked against the holo (ligand bound), apo, and homology modeled structures of 10 different enzyme binding sites. The holo and apo representations were crystallographic structures taken from the Protein Data Bank (PDB), and the homology-modeled structures were taken from the publicly available resource ModBase. The database docked was the MDL Drug Data Report (MDDR), a functionally annotated database of 95000 small molecules that contained at least 35 ligands for each of the 10 systems. In all sites, at least 99% of the molecules in the MDDR were treated as nonbinding decoys. For each system, the holo, apo, and modeled structures were used to screen the MDDR, and the ability of each structure to enrich the known ligands for that system over random selection was evaluated. The best overall enrichment was produced by the holo structure in seven systems, the apo structure in two systems, and the modeled structure in one system. These results suggest that the performance of the docking calculation is affected by the particular representation of the receptor used in the screen, and that the holo structure is the one most likely to yield the best discrimination between known ligands and decoy molecules, but important exceptions to this rule also emerge from this study. Although each of the holo, apo, and modeled conformations led to enrichment of known ligands in all systems, the enrichment did not always rise to a level judged to be sufficient to justify the effort of a docking screen. Using a 20-fold enrichment of known ligands over random selection as a rough guideline for what might be enough to justify a docking screen, the holo conformation of the enzyme met this criterion in eight of 10 sites, whereas the apo conformation met this criterion in only two sites and the modeled conformation in three.

Mesh:

Substances:

Year:  2003        PMID: 12825931     DOI: 10.1021/jm0300330

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  81 in total

Review 1.  Flexibility and binding affinity in protein-ligand, protein-protein and multi-component protein interactions: limitations of current computational approaches.

Authors:  Pierre Tuffery; Philippe Derreumaux
Journal:  J R Soc Interface       Date:  2011-10-12       Impact factor: 4.118

Review 2.  Nematode phospholipid metabolism: an example of closing the genome-structure-function circle.

Authors:  Soon Goo Lee; Joseph M Jez
Journal:  Trends Parasitol       Date:  2014-03-28

3.  Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?

Authors:  Hao Tang; Xiang Simon Wang; Jui-Hua Hsieh; Alexander Tropsha
Journal:  Proteins       Date:  2012-03-13

4.  Here be dragons: docking and screening in an uncharted region of chemical space.

Authors:  Ruth Brenk; John J Irwin; Brian K Shoichet
Journal:  J Biomol Screen       Date:  2005-09-16

5.  Decoys for docking.

Authors:  Alan P Graves; Ruth Brenk; Brian K Shoichet
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

6.  Discovery of protein phosphatase 2C inhibitors by virtual screening.

Authors:  Jessica P Rogers; Albert E Beuscher; Marc Flajolet; Thomas McAvoy; Angus C Nairn; Arthur J Olson; Paul Greengard
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

7.  Electrostatic evaluation of isosteric analogues.

Authors:  Roger Sayle; Anthony Nicholls
Journal:  J Comput Aided Mol Des       Date:  2006-07-15       Impact factor: 3.686

Review 8.  Modelling three-dimensional protein structures for applications in drug design.

Authors:  Tobias Schmidt; Andreas Bergner; Torsten Schwede
Journal:  Drug Discov Today       Date:  2013-11-08       Impact factor: 7.851

9.  Benchmarking methods and data sets for ligand enrichment assessment in virtual screening.

Authors:  Jie Xia; Ermias Lemma Tilahun; Terry-Elinor Reid; Liangren Zhang; Xiang Simon Wang
Journal:  Methods       Date:  2014-12-03       Impact factor: 3.608

10.  Recipes for the selection of experimental protein conformations for virtual screening.

Authors:  Manuel Rueda; Giovanni Bottegoni; Ruben Abagyan
Journal:  J Chem Inf Model       Date:  2010-01       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.